Herein we report our results concerning the clinical phenotype, dystrophin expression and DMD molecular analysis in 105 dystrophinopathy patients, presenting 98 different point mutations. Here, DMD is linked to neuromuscular disease caused by qualitative or quantitative defects of dystrophin.